Meet the Researcher: Ayokunle Olanrewaju

Ayokunle (Ayo) Olanrewaju is assistant professor of mechanical engineering and of bioengineering. His research applies 3D microfabrication, autonomous microfluidics and molecular assays to address medical challenges in treating infectious and chronic diseases, such as HIV, tuberculosis and cancer. He develops technologies for rapid and user-friendly monitoring of medications on an on-going basis to help patients adhere to drug dosing schedules, prevent treatment failure and improve health outcomes.

Novel nanoparticle shows promise for treating aggressive breast cancer

Zhang Lab
Scientists at the University of Washington have recently developed a new nanoparticle-based drug delivery system that simultaneously delivers chemo- and immune- therapeutics directly to the tumor site, limiting harmful off-target side effects. In a paper published last November in Materials Today, they reported that their multifunctional nanoparticle can inhibit tumor growth and spread, also known as metastasis, in mouse models of triple negative breast cancer, an exceptionally aggressive form of breast cancer with limited treatment options.